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chitinase 3-like protein 2 (CHI3L2) as a potential mediator of B12 deficiency in 
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London, UK; bPopulations, Evidence, and Technologies, Division of Health Sciences, Warwick Medical School, University of Warwick, 
Coventry, UK; cDepartment of Bioscience, School of Science and Technology, Nottingham Trent University, Nottingham, UK; dDivision of 
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ABSTRACT
Vitamin B12 has multiple biochemical functions including in the one-carbon cycle generating 
a methyl group for DNA methylation, and metabolism of fatty acids and amino acids to generate 
energy via the citric acid cycle. The aim of our study was to use a combined epigenomic and 
transcriptomic approach to identify novel genes mediating the effect of B12 on adipogenesis.
Human pre-adipocytes (CHUB-S7) were treated with a range of B12 (0–500 nM) concentrations 
from the day of cell seeding until harvesting in discovery and validation experiments prior to 
genome-wide methylation analysis using the Illumina HumanMethylation 450Beadchip. For tran-
scriptomic analysis, RNA-seq libraries were run on the Illumina HiSeq 2500. To further investigate 
the expression of any genes on human adipogenesis, a second human preadipocyte strain was 
studied (SGBS) by real-time quantitative PCR (qRT-PCR).
A combined epigenetic and transcriptomic approach in differentiated human pre-adipocyte 
cell line, CHUB-S7, identified that the Human cartilage chitinase 3-like protein 2 (CHI3L2) gene was 
hypo-methylated and had increased expression in low B12 conditions. Furthermore, there was an 
approximately 1000-fold increase in CHI3L2 expression in the early days of adipocyte differentia-
tion, which paralleled an increase of lipid droplets in differentiated SGBS cells and an increased 
expression level of markers of mature adipocytes.
In summary, we have identified a potential role of the human cartilage chitinase 3-like protein 
2 (CHI3L2) in adipocyte function in the presence of low B12 levels.
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Vitamin B12 (B12: cobalamin) is a key water- 
soluble vitamin required for many physiological 
and biochemical processes in the human body. 
B12 is produced by bacteria as hydroxycobalamin 
or derived synthetically (via bacterial fermentation 
and synthesis) as cyanocobalamin. Sources of B12 
therefore include most animal-derived foods, some 
fermented non-animal derived foods, or nutri-
tional supplementation. B12 deficiency varies 
widely from 2.5% to 26% [1]; even higher levels 
of deficiency are found in different sub- 
populations (i.e., children, young adults, pregnant 
women, and older adults) [1]. The classical 
complications of severe deficiency, although 
uncommon, are mainly seen in the haematological 
or nervous systems [1].
On a biochemical level, B12 has multiple func-
tions and is a crucial cofactor to two enzymes, 
methionine synthase (a methyltransferase) and 
methylmalonyl-CoA mutase. Methionine synthase 
enables the one-carbon cycle to use 5-methyltetra-
hydrofolate as a substrate to convert homocysteine 
to methionine and to generate a methyl group and 
tetrahydrofolate. The methionine produced from 
this cycle is metabolized via a transulfuration path-
way (the end product of which is the anti-oxidant 
glutathione), the methyl group is used for DNA 
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methylation, an epigenetic process, and tetrahy-
drofolate allows the synthesis of DNA and RNA, 
via purine and thymidine. Methylmalonyl-CoA 
mutase catalyses the conversion of methylmalonyl- 
CoA to succinyl-CoA, allowing downstream meta-
bolism of fatty acids and amino acids to generate 
energy via the citric acid cycle (TCA cycle) [1].
The role of B12 in these multiple biochemical 
pathways is critical to multiple physiological pro-
cesses in the human body. B12 has long been 
known to be required for haematopoiesis, with 
deficiency of the vitamin leading to neutrophil 
hypersegmentation and megaloblastic anaemia 
from impaired DNA synthesis in bone marrow 
due to reduced availability of purine and thymi-
dine [2]. Vitamin B12 deficiency in during early 
life is associated with growth and developmental 
neurological disorders, whereas during adulthood 
can cause neuropathy and neuropsychiatric disor-
ders [3]. The crucial role of B12 in the utilization 
of fatty acids and amino acids to produce energy 
(as ATP) via the TCA cycle, as well as for mito-
chondrial functions, has potentially wide implica-
tions for a multiple cellular process. Recent studies 
have now shown a clear association of vitamin B12 
deficiency with increased fat mass and an adverse 
lipid profile (including increased LDL and choles-
terol-to-HDL ratio and low HDL) [4,5]. The pre-
cise cellular mechanisms by which B12 deficiency 
exerts these effects, e.g., via altered DNA synthesis, 
reduced utilization of fatty acids for energy pro-
duction, or reduced glutathione synthesis, are not 
yet known.
The key role of methionine synthase in the 
generation of methyl groups for DNA methyla-
tion, implicates B12 as a crucial determinant of 
cellular DNA methylation. We, and others, have 
therefore hypothesized that vitamin B12 status 
may influence epigenetic processes, and could 
offer a molecular mechanism by which an indi-
vidual’s environment (e.g., diet) can influence 
gene function. We have previously identified 
that vitamin B12 deficiency is associated with 
decreased DNA methylation, due to decreased 
ratio of S-adenosylmethionine (SAM) to 
S-adenosylhomocysteine (SAH), the intermedi-
ates in the conversion of homocysteine to 
methionine, and increased expression of two 
gene regulators of cholesterol biosynthesis, 
SREBF1 and LDLR [6]. Others have shown 
adverse metabolic phenotypes associated with 
B12 deficiency in in vivo models, including 
increased fat mass, fasting glucose and insulin 
resistance including in programming models 
[4,6–9]. Additional research implicates 
a reduced SAM:SAH ratio in reduced methyl 
group availability for DNA methylation [10].
We therefore sought to investigate the role of 
B12 on DNA methylation across the epigenome, 
and its consequent impact on gene expression. We 
used an in vitro model of human adipogenesis to 
elucidate the potential of B12 deficiency to impair 
metabolic processes, as suggested by published 
in vivo research. To do so, we took a discovery- 
based approach to study the epigenome (using the 
Illumina HumanMethylation450 BeadChip) in 
CHUB-S7, a human pre-adipocyte cell line, 
exposed to varying concentrations of vitamin B12 
during development and growth. We then vali-
dated our findings in a second experiment under 
the same conditions). Subsequently, we performed 
an integrated analysis of the validated methylation 
top hits and gene transcription using RNA-seq and 
bioinformatics analysis to identify the functional 
effects of B12 deficiency in adipogenesis. On iden-
tifying a credible candidate, we investigated its 
expression during adipogenesis in a second 
human pre-adipocyte strain (SGBS).
Materials and methods
Culture and differentiation of human 
pre-adipocytes in CHUB-S7 for discovery and 
validation experiments
Human preadipocyte cell line Chub-S7 were cul-
tured and differentiated as previously described 
[6,11]. Briefly, using the custom-made B12- 
deficient DMEM/F12 growth media supplemen-
ted with 10% foetal bovine serum (FBS), 1% 
L-glutamine and 1% streptomycin and/ penicil-
lin, the pre-adipocytes were cultured in a T-75 
flask. At confluence in the T-75 flask, the cells 
were trypsinized and seeded into six-well plates 
at 10,000 cells per well in three different con-
centrations of B12 in DMEM/F12 growth media 
such as: (1) Control: ‘normal’ B12 – 500 nM (2) 
Low B12: B12 – 0.15 nM and (3) No B12: (B12 – 
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0 nM) (Figure 1(a)). The respective DMEM/F12 
growth media for each condition was changed 
every 48 hours until 100% confluence was 
achieved. Following attainment of 100% conflu-
ence in the growth media (day 0), the preadipo-
cytes were differentiated in custom-made B12- 
deficient DMEM/F12 differentiation media 
(DM) for 72 h (day 03) and thereafter were 
maintained in custom-made B12 deficient 
DMEM/F12 nutrition media (NM) for 11 days 
(day 14). The day differentiation was initiated 
(at confluence) was considered as day 0 and 
the differentiated adipocytes were harvested 
on day 14. For methylation inhibition experi-
ment, preadipocytes were incubated with 
200 nM of 5-aza-2'-deoxycytidine (5-Aza-dC) at 
50% confluency for 72 h and were differentiated 
at confluence (Figure 1(b)). Folate conditions 
(6 µM) were kept constant across all experimen-
tal groups (both the discovery and validation 
experiments).
The discovery experiment was performed in cell 
cultures exposed to three different B12 conditions 
and a fourth exposure of Control + methylation 
inhibitor (‘Control’, ‘low’, ‘no’, ‘Control+5-Aza- 
dC’) (Table 1). In the validation experiment the 
same cell culture methods were used as in discov-
ery experiment for the three B12 conditions, apart 
from the fourth exposure, using the methylation 
inhibitor (Table 1). All downstream experiments 
were performed on triplicate samples from each 
experimental group.
DNA and RNA extraction (CHUB-S7)
On day 14, the differentiated adipocytes were tryp-
sinized, pelleted by centrifugation and the super-
natant was discarded. Cell pellets were snap-frozen 
in liquid nitrogen and stored at −80°C prior to 
RNA and DNA extraction (using the RNeasy Lipid 
Tissue Kit and DNeasy Blood and Tissue Kit; 
Qiagen, Venlo, Limburg, according to manufac-
turer’s protocol).
Figure 1. Study design of discovery experiment.
Legend: CHUB-S7 cells were treated with a range of B12 conditions – Control: B12 – 500 nM, Low B12: B12 – 0.15 nM, No B12: B12 – 
0 nM (n = 3) (Figure 1(a)); control and the addition of a methylation inhibitor 5-aza-2'-deoxycytidine (5-Aza-dc) (Figure 1(b)) 
Table 1. Summary of cell culture B12 and folate conditions in 











No B12 0 6 0 6
Low B12 0.15 6 0.15 6
Control (‘normal B12') 500 6 500 6
Control + methylation 
inhibitor






Legend: 5-Aza-dC is the methylation inhibitor 5-aza-2ʹ-deoxycytidine 
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DNA methylation and bioinformatic analysis 
(CHUB-S7)
High-quality genomic DNA was bisulphite- 
converted using EZ-96 DNA Methylation Kit 
(Zymo Research, Irvine, CA, USA) according to 
manufacturer’s protocols. Genome-wide DNA 
methylation analysis was performed using 
Illumina HumanMethylation 450Beadchip 
(‘methylation array’; Illumina, San Diego, CA, 
USA) on sample triplicates from the four experi-
mental groups in the discovery experiment 
(Table 1), and three in the validation experiment 
(Table 1). Methylation array analysis methods are 
as described previously [6,12]. Data were filtered 
to remove cross-hybridizing probes, X and 
Y chromosome probes and those with a detection 
p value of ≥0.05. Data were quantile normalized 
per colour channel, per bead and per tissue type; 
a method shown to reduce standard error with 
high performance. Non-hierarchical clustering 
was performed to exclude positional or batch 
effects and to look for methylation differences 
across all array probes being used in analysis. 
Beta Mixture Quantile (BMIQ) normalization 
method was used to correct for the two different 
probe types contained on the array. Analysis of 
differentially-methylated positions (‘DMPs’) was 
performed using open-source R-based software 
including Limma, and Benjamini and Hochberg 
false discovery rate control was applied.
RNA-seq and bioinformatic analysis (CHUB-S7) in 
discovery experiment
OligodT beads enriched poly-A mRNA isolated 
from cellular total RNA was used to construct 
multiplexed strand-specific RNA-seq libraries 
using the Illumina TruSeq Total RNA Library 
Prep Kit (Illumina, San Diego, CA, USA) follow-
ing the manufacturer’s protocols. Individual 
libraries were quality checked on an Agilent 2100 
Bioanalyzer and quantified on QuBit 2.0 fluorom-
eter. Libraries were indexed, pooled and amplified, 
then sequenced on the Illumina HiSeq 2500.
RNA-seq data was mapped using appropriate 
software (Tophat, Bowtie 2 and samtools) with 
default settings. Mean insert sizes and standard 
deviations were calculated in silico using Picard 
Tools from 1,000,000 reads. Duplicates were fil-
tered using Picard Tools and reads were assigned 
to a gene using HTSeq. Analysis of differential 
gene expression was performed using DESeq2, 
applying a generalized linear model in which 
counts are modelled using a negative binomial 
distribution. Genome-wide corrected p values 
were calculated using Benjamini-Hochberg multi-
ple testing adjustment procedure. Normalized var-
iance stabilizing transformed counts were used for 
all plots and further analysis.
Culture and differentiation of human 
pre-adipocytes in SGBS
Following experimentation with CHUB-S7 the top 
hit was studied functionally in the Human 
Simpson Golabi Behmel Syndrome (SGBS) [13] 
pre-adipocyte cell strain. Human SGBS pre- 
adipocytes were maintained by twice weekly pas-
sages in DMEM/Ham’sF12 (1:1) medium 
(Invitrogen, Paisley, UK) containing ‘normal’ B12 
(500 nM) and folate (6 μM) levels (Table 1), 10% 
foetal calf serum (FCS; Invitrogen), 100 U/ml 
penicillin (Invitrogen), 100 μg/ml streptomycin 
(Invitrogen), 33 μM biotin and 17 μM pantothe-
nate as previously described [6,14]. Differentiation 
of SGBS was performed according to Wabitsch 
et al. [13] and Fischer-Posovszky et al. [15] proto-
cols. Briefly, initiation of SGBS cells differentiation 
into adipocytes was done using 60–80% confluent 
cells in T175 flasks. Cells were washed three times 
with PBS and cultured in FCS-free differentiation 
induction medium (DIM) (DMEM/Ham’s F12 
(1:1) medium supplemented with 100 U/ml peni-
cillin, 100 μg/ml streptomycin, 33 μM 
biotin,17 μM pantothenate, 10 μg/ml human 
transferrin, 10 nM insulin, 100 nM hydrocorti-
sone, 0.2 nM triiodothyronine, 25 nM dexametha-
sone, 500 μM 3-isobutyl-1-methylxanthine 
(IBMX) and 2 μM rosiglitazone (Cayman 
Chemical, Ann Arbor, MI, USA). After 4 days, 
this induction medium was replaced with differ-
entiation medium (Induction medium without 
dexamethasone, IBMX and rosiglitazone), and 
incubated for a further 20 days with regular fresh 
induction media changes every 3–4 days. SGBS 
cells were regularly collected at days 0 (D0), 4 
(D4), 8 (D8), 11 (D11), 14 (D14) and 18 (D18) 
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for oil red lipid staining and gene expression 
analysis.
Oil red O lipid staining of differentiated SGBS 
cells
Lipid droplets in differentiated SGBS adipocytes 
cells were detected using Oil Red O (ORO) stain-
ing (Sigma-Aldrich) following the manufacturer’s 
instructions. ORO-stained SGBS adipocytes were 
observed under fluorescence microscope (iRiS™ 
Digital Cell Imaging System, Logos Biosystems, 
Inc) and digital images were captured at 4× and 
10× magnification.
Real Time-quantitative PCR (qRT-PCR) analysis of 
differentiated SGBS cells
For qRT-PCR analyses, cells were trypsinized, 
immediately lysed in RLT buffer and then RNA 
extracted using spin-column–based RNEasy Mini 
Kit method according to manufacturer’s instruc-
tions (Qiagen; Hilden, Germany). Extracted RNA 
was quantified on NanoDrop spectrophotometer 
(Nanodrop Technologies; Montchanin, DE). One 
microgram total RNA from each sample was 
reverse transcribed using SuperScript IV First- 
Strand reverse transcriptase synthesis kit 
(Thermo Fisher Scientific), according to the man-
ufacturer’s instructions.
Expression analysis of chitinase 3-like 2 was 
done using CHI3L2 Thermofisher TaqMan® gene 
expression assays Hs00970220_m1 (targeting exon 
6–7) and Hs00970217_m1 (targeting exon 3–4) 
(220-CHI3L2 and 217-CHI3L2) (Table 2). 
Expression assay to genes involved in adipocyte 
differentiation, such as Peroxisome proliferator- 
activated receptor gamma (PPARG), CCAAT 
enhancer binding protein alpha (CEBPA), leptin 
(LEP), and lipopolysaccharide binding protein 
(LBP) [16,17] (ThermoFisher) was used to follow 
differentiation stages of SGBS cells using qRT-PCR 
(Table 2). These specific oligonucleotides manu-
factured by Applied Biosystems (Thermo Fisher 
Scientific) were used following manufacturers 
instruction with TaqMan™ Fast Advanced Master 
Mix (Thermo Fisher Scientific). qRT-PCR reaction 
conditions were cDNA denaturation at 95°C for 
5 min, cDNA amplification at 95°C for 15 s, pri-
mers annealing at 62°C for 1 min for 45 cycles, 
then melt curve was obtained at 95°C for 15 s, 
60°C for 1 min and a final step at 95°C for 15 
s. qRT-PCR results were analysed using Thermo 
Fisher StepOne software v2.3. Results were nor-
malized using the Applied Biosystems® Human 
GAPD (GAPDH) Endogenous Control (FAM™ 
Dye ⁄ MGB Probe, as reference housekeeping 
gene, and evaluated using the 2−ΔΔCt method and 
compared to control samples [18].
Results
CHUB-S7 cell line
B12 treatment had no significant effect on cell 
viability and there were no gross microscopic dif-
ferences in cell morphology.
DNA methylation analysis
11,648 probes mapping to chromosome X and 
Y were removed. 40,590 probes were removed 
due to the probes being non-specific as suggested 
in Price et al. [19] and 369 probes were removed 
with a detection p value < 0.05. This resulted in 
a total of 432,905 probes used for all further ana-
lysis. The ‘Control (‘normal B12') + methylation 
inhibitor’ samples showed significant reduction in 
methylated probes with a peak of methylation now 
occurring just below 0.8 beta value compared to 
0.9 for all other samples (Figure 2(a)). Therefore, 
Table 2. ThermoFisher expression assays.
Gene name Gene symbol ThermoFisher TaqMan-Assay ID Ref seq Exon boundary
Chitinase 3-like 2 CHI3L2 Hs00970217_m1 NM_001025197.1 Ex-3-ex-4
Chitinase 3-like 2 CHI3L2 Hs00970220_m1 NM_001025197.1 Ex-6-ex-7
CCAAT/enhancer binding protein alpha CEBPA Hs00269972_s1 NM_001285829.1 Exon 1
Liopolysaccharide binding protein LPB Hs01084628_m1 NM_004139.4 Ex-8-ex-9
Peroxisome proliferator activated receptor gamma PPARG Hs01115513_m1 NM_005037.5 Ex-4-ex-5
Leptin LEP Hs00174877_m1 NM_000230.2 Ex-2-ex-3
Legend: Ex = exon 
EPIGENETICS 5
Figure 2. Density and Hierarchical plots in the discovery experiment.
Legend: Density plot of all (filtered) probes in the discovery experiment for each sample before normalization (Figure 2(a)). Hierarchical plot of 
normalized beta values for each sample (Figure 2(b)). ‘Control + Inhibitor’ was removed before the normalization procedure due to the global 
methylation change Figure 2(a). The Y axis shows a quantitative measure of methylation, determined per plot. 
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these samples were removed prior to quantile nor-
malization. Mean methylation values before nor-
malization across all filtered probes were no 
different in the low, no and control conditions 
(beta values 0.480, 0.472, 0.466 (p value >0.01) 
suggesting no large global changes in methylation 
at 432,905 probes measured due to B12 condition. 
Hierarchical clustering of quantitative methylation 
at filtered probes (Figure 2(b)) showed the largest 
methylation differences occurring between the 
control (‘normal B12') and other groups (‘low 
B12’ and ‘no B12’).
DNA methylation differences were identified in 
comparison of ‘Control’ versus ‘No B12’ with 4 
probes reaching genome-wide significance using 
t-test based statistics and Benjamini and 
Hochberg control of false discovery (adjusted 
p < 0.05) (Figure 3(a)). All four probes had lower 
methylation in ‘No B12’ samples compared to the 
‘Control’ samples with an absolute beta value dif-
ference > 0.1. In the comparison between ‘Low 
B12’ and ‘Control’ we found no significant differ-
ences although three probes showed nominal sig-
nificance (q value = 0.0503). We also found 
‘cg26366091’ to show similar differences to that 
of the ‘No B12’ vs ‘Control’ with a q value = 0.062.
To validate these findings, we performed 
a second Illumina 450 K experiment using newly 
derived samples from three experimental groups: 
‘No B12,’ ‘Low B12’ and ‘Control’ (see Table 1 – 
replication experiment). We found that three of 
the four probes (‘cg26366091,’ ‘cg10298741’ and 
‘cg26215727’) showed the same significant differ-
ence in methylation between the ‘No B12’ and 
‘Control’ samples (Figure 3(b)). All four probes 
also showed significant differences in methylation 
between ‘Low B12’ and ‘Control’ although probe 
‘cg06041466’ had an absolute beta difference <0.05 
so is unlikely to be real. Therefore, we have found 
three replicated probes, which show significant 
hypo-methylation in response to reduced B12 
levels.
Examining the location of each of the four 
probes suggested that only cg26366091 
(CHI3L2) was likely to be transcriptionally rele-
vant. Hence, cg06041466 (FMO6P) is located 
110bp to the nearest transcription factor (TF) 
binding site (FOXO3/4) and 480bp away from 
the nearest transcriptional start site (TSS). 
cg26215727 (SCNN1A) is located 39bp to the 
nearest TF binding site (PPARA) and 198bp 
away from the nearest TSS. cg10298741 
(ZFHX3) is located 51bp to the nearest TF bind-
ing site (HNF1). Therefore, cg06041466, 
g26215727 and cg10298741 are all unlikely to 
interfere with TF binding directly. In contrast, 
cg26366091 (CHI3L2) is located only 28bp away 
from the highest ranking TSS for CHI3L2 and 
therefore may interfere directly with the gene 
transcription machinery.
Combined analysis of 450K methylation and 
RNA-seq expression data at methylation top hits
We next took these three DMPs identified in both 
discovery and replication experiments forward in 
subsequent functional analysis. We interrogated 
RNA-seq expression data in the discovery set 
(log2FC) from the genes where these DMPs were 
located (Figure 4) and correlated methylation dif-
ference with expression difference. Of the three 
DMPs only a single probe, located within the 
promoter near to CHI3L2 showed a decrease in 
methylation and a significant increase in expres-
sion (q = 1×10−18). To investigate this further we 
checked the region around the transcriptional start 
site of CHI3L2 for other probes contained on the 
Illumina 450 K array. In total, we have four probes 
which assay the methylation in this region, the two 
found previously and two further probes, one 
upstream of the promoter and one contained 
within the gene body which both show no differ-
ence due to B12 conditions suggest the methyla-
tion difference is located within the region close to 
the transcription start site (Figure 5(a)). 
Interestingly, we found using non-normalized 
data that in the inhibitor sample this region also 
undergoes a reduction in methylation and shows 
increased expression of the gene (Figure 5(b)).
CHI3L2 is flanked on one side with CHIAP1 
(Chitinase, Acidic Pseudogene 1), which is 
a Pseudogene. No differential expression in RNA- 
seq top hits were found for this gene. On the other 
side of CHI3L2, the closest gene is DENND2D and 
then CEPT1. DENND2D (DENN Domain 
Containing 2D) is a protein coding gene, which 
acts as a guanine nucleotide exchange factor that 
may activate RAB9A and RAB9B. Interestingly, in 
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Figure 3. Volcano plots in discovery and replication experiment.
Legend: Figure 3(a) A volcano plot of the 432,905 probes measured in the discovery experiment. The x-axis is the mean Beta 
difference between ‘No’ and ‘Control’ samples and y-axis is the negative logarithm of the genome wide corrected p value. Blue 
dashed line represents a beta value difference of 0.1 and red dashed line represents a genome wide corrected p value 0.05. The four 
probes reaching genome wide significance are highlighted in red with their associated gene. Figure 3(b) A volcano plot of the 
432,738 probes measured in the replication experiment. The four probes highlighted in red are those that reached genome wide 
significance in the discovery experiment (also highlighted in Figure 3(a)). 
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our RNA-seq dataset this gene was also differen-
tially expressed (Log2FC −1.5; q = 3.9E-09) com-
pared to CHI3L2 (Log2FC −2.1; q = 1.04E-18E). 
CEPT1 codes for a choline/ethanolaminephospho-
transferase. No differential expression in RNA-seq 
top hits were found for this gene.
In the RNA-seq experiment 407 genes were 
found to significantly (q < 0.01 and log2FC >1.5) 
differentially expressed between control (‘normal 
B12') and no B12 conditions; these are listed in the 
supplementary table.
Investigation of CHI3L2 expression during 
human adipogenesis
Genome-wide association analysis (GWAS) stu-
dies have previously linked genetic variants within 
and in linkage disequilibrium with CHI3L2 gene to 
metabolic phenotypic traits, including cholesterol 
and triglycerides levels [20]. The strong genetic 
link between CHI3L2 and blood lipid phenotypes, 
combined with our previous observations of asso-
ciation of low B12 levels with increased cholesterol 
biosynthesis [6] prompted us to investigate 
CHI3L2 expression during adipogenesis. Rather 
than restrict our analysis to one human pre- 
adipocyte line (CHUB-S7), we used a classical 
in vitro model of human white pre-adipocytes 
differentiation, the Simpson Golabi Behmel 
Syndrome (SGBS) cell line [13,15]. Morphological 
changes during the cellular differentiation and 
phenotype in SGBS cells were confirmed by Oil 
red O lipid staining (Figure 6). An increase of lipid 
droplets accumulation in SGBS cytoplasm could be 
readily observed over time (Figure 6), consistent 
with emergence of differentiated adipocytes.
The expression of CHI3L2 and adipogenesis 
markers including PPARG, CEBPA, LEP, and 
LBP were assessed in SGBS cells at different devel-
opmental stages of differentiation (from D0 to 
D18) using qRT-PCR assay (Figure 7). Mean levels 
of CHI3L2 were found to increase approximately 
1000-fold by day 4 of SGBS adipocyte differentia-
tion (Figure 7(a-b)) in the presence of ‘normal 
vitamin B12 conditions’); this is mirrored by an 
increase in gene expression of CEBPa, LBP, LEP, 
and PPARG (Figure 7(c-f)) that are markers of 
adipocyte differentiation. Between days 11 and 
12, the expression of all genes decreased. To 
further investigate these findings, we interrogated 
Figure 4. Methylation difference between ‘No’ and ‘Normal’ versus log2FC gene expression at replicated hits, displayed by gene 
name.
Legend: Results from both methylation and expression studies are from the discovery dataset 
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the RNA-seq data from the discovery experiment 
in CHUB-S7 cells. Comparing no B12 with control 
(‘normal’) B12 conditions, revealed significant 
expression changes for LBP (q = 3E-23 and 
log2FC = 2), PPARG (q = 4E-8 and 
log2FC = −0.8) and LEP (q = 0.001 and 
log2FC = 0.5).
Discussion
Combined RNA-seq and DNA methylation analy-
sis of CHUB-S7 human pre-adipocytes cultured in 
the presence or absence of vitamin B12 revealed 
that the Human cartilage chitinase 3-like protein 2 
(CHI3L2) gene was hypo-methylated and conse-
quently had an increased expression in B12 defi-
ciency conditions.
CHI3L2 is a chitinase 3-like 2 protein which is 
part of the glycohydrolase family 18. This family 
includes two chitinases that are CHIA (acidic 
mammalian chitinase) and CHIT1 (chito- 
triosidase) and four chitinase-like proteins includ-
ing CHI3L1 (chitinase 3-like 1); CHI3L2 (chitinase 
3-like 2); CHID1 (stabilin 1-interacting chitinase- 
like protein and OVGP1 (oviductin) [21,22].
Chitinases are enzymes that degrade chitin, 
which constitute the cell wall of fungi. They play 
an important role in both innate and adaptive type 
2 immune responses [23–25]. Chitinase-like pro-
teins are structurally similar to chitinase proteins 
and can bind chitin, but they lack the enzymatic 
activity [26]. The most representative chitinase- 
like proteins are CHI3L1 and CHI3L2 [27].
CHI3L2 is poorly characterized but known to be 
involved in cartilage biosynthesis via binding of 
chito-oligosaccharides and glycans in humans 
[28]. CHI3L2 has also been shown to activate 
ERK1/ERK2 and regulate promoters of cell growth 
[29], is associated with the progression of neuro-
degeneration in motor cortex and spinal cord of 
amyotrophic lateral sclerosis sALS patients [27], 
and is regulated by miRNAs. Li et al. [30], have 
also reported that miR-216a-5p is involved in dia-
betes and targeted genes including CHI3L2. 
Furthermore, the chitinases including, CHIA, 
CHIT1, CHI3L1, CHI3L2, and CHID1, have 
a central role in the monocyte lineage and chronic 
inflammatory disease [31].
Interestingly, Neurospora crassa is a class of 
fungi known for its ability to convert homocys-
teine to methionine using vitamin B12- 
independent methionine synthase. In other organ-
isms (apart from plants), methionine synthase 
requires vitamin B12 to convert SAH to SAM in 
the one-carbon cycle [32]. In this process, methio-
nine is converted to AdoMet, a universal methyl 
group donor for methylation of DNA and RNA 
[6]. We have shown that lack of vitamin B12 
regulates the methylation of SREBF1 and LDLR 
genes by limiting the synthesis of methionine and 
Figure 5. Combined analysis of methylation and expression data from the discovery dataset restricted to CHI3L2.
Legend: Figure 5(a) Differential methylation at an example top hit, CHI3L2. Colour coding as per hierarchical cluster plots, i.e., 
green = control, blue = low B12, red = no B12. Figure 5(b) Comparison of Expression of CHI3L2 to that of the methylation of 
cg26366091 within the promoter of the gene. A strong correlation with methylation and transcription is seen (p value = 0.012 
rho = −0.71). 
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this in turn activates cholesterol production [6]. 
Overproduction of adipose cholesterol and trigly-
cerides may lead to adipocytes dysfunction and 
obesity resulting in metabolic complications and 
insulin resistance [33].
Monocyte-derived cell lines, activated macro-
phages and neutrophils express chitinases and 
chitinase-like proteins, in response to proinflam-
matory cytokines in various tissues. Mammalian 
chitinases catalyse the hydrolysis of chitin produ-
cing pathogens and are involved in immune reg-
ulation and inflammatory responses to bacterial 
infection, tissue inflammation, metabolic disorder, 
and degenerative disease [25].
In obese individuals, subcutaneous adipose tis-
sue dysfunction may result in impaired triglycer-
ides storage and possibly diversion of free fatty 
acids to the liver or the visceral compartment. 
Adipose tissue inflammation can occur once this 
condition is established, culminating in higher 
secretion of proinflammatory cytokines and 
macrophage infiltration. In adipose tissue from 
obese mice and humans, infiltrated macrophages 
can aggregate around dead adipocytes forming 
Figure 6. Oil red O lipid and DAPI staining of SGBS cells at different stages of differentiation from day 0–18 (10× magnification).
Legend: DAPI staining of nuclei in blue, RFP staining of cells in red 
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ring patterns called crown-like structures (CLS) 
[34]. The presence of CLS is associated with insu-
lin resistance and macrophages within CLS have 
been shown to be proinflammatory [35]. Lê et al. 
[34], showed that CHI3L2 was one of the top 15- 
upregulated genes in CLS+ compared with CLS- 
individuals. CHI3L2 was first isolated from carti-
lage cells culture [36]; however, it has also been 
demonstrated that production of CHI3L2 is stimu-
lated by IFN-γ or IL-4 and released by activated 
macrophages as response to autoimmune reac-
tion [37].
In studies of the second human cell line SGBS 
there was an approximately 1000-fold increase in 
CHI3L2 expression in the early days of differentia-
tion, which paralleled an increase of lipid droplets 
in differentiated SGBS cells and an increased 
expression level of markers of mature adipocytes 
when cultured in conditions of ‘normal’ vitamin 
B12. These findings are supported by recent stu-
dies, in which CHI3L2 was found to correlate with 
lipid droplet size and high lipogenic capacity [38]. 
Our results and those of others therefore suggest 
that CHI3L2 may play a role, and potentially be 
used as a marker for adipocyte differentiation. 
A limitation of our qualitative approach was that 
when we cultured the SGBS cells, we only used 
DMEM/Ham’sF12 (1:1) media that contains 
500 nM B12 (same as control B12 used for CHUB- 
S7) and did not compare it to SGBS cells incubated 
with low or no B12 media. However, further inter-
rogation of the RNA-seq data in CHUB-S7 cells 
comparing no B12 with control (‘normal’) B12 
conditions, revealed significant expression changes 
for LBP, PPARG and LEP which is consistent and 
supports the findings in SGBS cells.
In the discovery experiment significant changes 
in methylation were observed in addition to 
CHI3L2: ZFHX3, SCNN1A, and FMO6P. 
However, whereas in the replication experiment, 
although the findings for CHI3L2, ZFHX3, and 
SCNN1A were confirmed, that for FMO6P was 
not validated. We did not further follow-up 
ZFHX3 and SCNN1A in SGBS cells, since they 
Figure 7. Gene expression analysis during SGBS cellular differentiation.
Legend: Triplicate qRT-PCR results from markers of cell differentiation genes: panels (a) CHI3L2-220, panel (b) CHI3L2-217, panel (c) 
CEBPA, panel (d) LBP, panel (e) LEP, and panel (f) PPARG; the triplicate experiments (exp) are labelled 01 (blue), 02 (red) and 03 
(green) and the fourth curve in black (downward triangle) is the mean. The CHI3L2 qRT-PCR assays targeted exons 6–7 (panel a:220- 
CHI3L2) and exons 3–4 (panel b:217-CHI3L2) using Thermofisher TaqMan® gene expression assays ID Hs00970220_m1 and 
Hs00970217_m1 respectively. 
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were not significant in the genome-wide transcrip-
tomic study defined by a q value of <0.01 and 
log2FC of 1.5. However, there is not always 
a perfect correlation between gene methylation 
and expression at a single time point, especially if 
the methylation site is outside the promoter or in 
the body of the gene [39]. Therefore, given the 
consistency between discovery and validation 
experiments for methylation, the potential rele-
vance of the ZFHX3 and SCNN1A for adipogenesis 
are discussed further.
ZFHX3 is the zinc finger homeobox 3 circadian 
rhythm gene that encodes a transcription factor 
with multiple homeodomains and zinc finger 
motifs. Its function has been reported as tumour 
suppressor for several cancers and sequence var-
iants have been associated with atrial fibrillation 
(Entrez gene summary). Interestingly, in genome 
wide association a strong association is seen 
between ZFHX3 and BMI (p = 2.3 E-22) (https:// 
t2d.hugeamp.org/; T2D portal last accessed 
9 August 2021) Furthermore, low-frequency cod-
ing variants of ZFHX3 have been found by Turcot 
and colleagues [40], that has a potential role in 
adiposity. Genes flanking ZFHX3 include the pseu-
dogenes: KRT18P18, RPSAP56, and RNAU7-71P 
and the transcript HCCAT5, none of which were 
differentially expressed depending on the B12 con-
centration in our experiments.
SCNN1A is the sodium channel epithelial sub- 
unit alpha/sodium permeable non-voltage- 
sensitive ion chain. An association of SCNN1A 
variants with waist to hip ratio adjusted for BMI 
has been described (https://t2d.hugeamp.org/; 
T2D portal last accessed 9 August 2021);, but 
there is no further evidence of this gene being 
important to adipogenesis or weight regulation. 
Genes flanking SNN1A include LTBR, 
TNFRSF1A, and the pseudogene RN7SL391P. 
The lymphotoxin beta gene (LTBR) is an inter-
esting candidate for adipocyte function since 
LTBR signalling has anti-adipogenic action 
through NF-kB pathways [41]. Furthermore, like 
SCNN1A, a strong association is documented 
between LTBR and waist hip adjusted for 
BMI (https://t2d.hugeamp.org/;T2D portal last 
accessed 9 August 2021). In our RNA-seq data, 
the expression of this gene was not differentially 
expressed between control (‘normal B12') and no 
B12 conditions.
This differentiation process in the discovery and 
validation experiments mimics the in vivo embryo-
nic differentiation period during the developmental 
stages. Pre-adipocytes were cultured in the custom- 
made B12 deficient/sufficient media at very low cell 
number, such as 10,000 per well until confluence, 
where cells undergo multiple doublings, then adi-
pocyte differentiation was started by restricting the 
nutrition (FBS), and thereafter, supplementing with 
nutrition media for fully differentiated adipocytes. 
Searching the EWAS catalogue beta (http://www. 
ewascatalog.org/) (last accessed 9 August 2021) 
methylation changes for cg06041466 (FMO6P), 
cg26366091 (CHI3L2), cg26215727 (SCNN1A), 
and cg10298741 (ZFHX3) have not been studied 
in adipocytes or their differentiation. Nonetheless, 
significant changes in methylation were found in 
these cpg sites in all four genes, in several human 
tissues including whole blood, PBMNCs and cord 
blood, in relation to early childhood and gestational 
age, which may have relevance to the current study 
especially for adipogenesis.
Two studies have investigated potential methy-
lation changes related to diet. Chamberlain and 
colleagues [42] studied the dietary intake of one- 
carbon metabolism nutrients using a food fre-
quency questionnaire and DNA methylation on 
peripheral blood. They concluded that there ‘is 
little association with blood DNA methylation.’ 
Mandaviya and colleagues [43] focussed on both 
folate and vitamin B12 intake. For B12, they found 
29 differentially methylated regions of which the 
most significant spanned a region spanning the 
calcium-binding tyrosine phosphorylation- 
regulated gene (CABYR). However, vitamin B12 
intake was not associated with any differentially 
methylated positions. Methylation changes in rela-
tion to B12 for either CHI3L2, FMO6P, or 
SCNN1A were not described in either publication 
or in the EWAS catalogue.
Although a weakness of our conclusions regarding 
CHI3L2, is that it is based on in vitro work alone, we 
have used two separate human cell lines and have 
a robust methylation signature using both discovery 
and validation experiments. Furthermore, the methy-
lation effect correlates with the findings by RNA-seq 
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and a functional effect. Whilst CHI3L2 expression is 
associated with neurological pathology (amyotrophic 
lateral sclerosis, Alzheimer’s disease, and glioblas-
toma), carcinogenesis (renal and pancreatic cancer) 
and osteoarthritis, this is the first report suggesting 
a role in the adipogenesis and its regulation by vita-
min B12.
In summary we demonstrate how epigenetic 
modifications impact the transcriptome and 
a single nutrient can induce global gene expression 
changes. More specifically, we have identified 
a potential role of the human cartilage chitinase 
3-like protein 2 (CHI3L2) in adipocyte function in 
the presence of low B12 levels.
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